“IVF” Successfully Completes IPO Subscription, Set to Begin Trading on the mai Exchange on December 11

Inspire IVF Public Company Limited (“IVF”) successfully completed its initial public offering (IPO) of up to 130 million shares at an offering price of THB 3.10 per share, representing a total offering value of up to THB 403 million. Following the IPO subscription period from November 29 to December 3, 2024, the offering received strong positive interest from investors, with the shares fully subscribed before the closing date. IVF is scheduled to commence trading on the Market for Alternative Investment (mai) on December 11, 2024.

Dr. Woranan Thawornnan, Executive Director and Managing Director of Kingsford Securities Public Company Limited, stated that IVF’s IPO offering of 130 million shares represented no more than 29.55% of the company’s total issued and paid-up shares. The offering received overwhelming interest from investors, raising a total of THB 403 million. This reflects investor confidence in IVF’s business potential and the strong growth outlook of the fertility treatment industry, driven by factors such as the global expansion of the fertility tourism market, Thailand’s position as a medical hub, and continuous advancements in medical technology.

In addition, IVF’s strong operating performance over the past three years further highlights the company’s growth potential. Revenue increased steadily from THB 11.24 million in 2021 to THB 63.31 million in 2022 and THB 121.55 million in 2023, with the majority generated from fertility treatment services. These results reinforce the company’s ability to generate profits and achieve sustainable growth, making “IVF” a company to watch with the potential to deliver attractive returns to investors.

Ms. Kesinee Kuldilok, Chief Executive Officer of Inspire IVF Public Company Limited (“IVF”), said that listing on the mai Exchange marks a significant milestone for Inspire IVF. The company aims to leverage its expertise and accumulated experience to further enhance fertility treatment services, with the goal of becoming a leading fertility treatment center trusted both nationally and across Asia.

The funds raised from the IPO will be allocated for working capital of THB 84 million, expansion of new branches totaling THB 190 million, and investment in related businesses, including wellness services, totaling THB 114 million.

“I would like to express my sincere gratitude to all investors for their trust and support toward Inspire IVF. We are committed to operating our business with transparency, fairness, and strong corporate governance. Our goal is to become a leading fertility treatment center with international standards at both the national and Asian levels, supporting the future growth of fertility tourism while creating stable and sustainable value for all stakeholders, including shareholders, employees, partners, and society as a whole.”

Source: https://thunhoon.com/article/305358 by Thunhoon